DUR-29746-35658
2 vaccinations
6 coded responses
15 check-ins
6 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 757 / TX
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-27
- 2020-12-28
- 2020-12-30
- 2021-01-07
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-01-19
-
2021-01-26
Survey response — day 14, dose 2MedDRA: Pain — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Generalized body achesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-02
Survey response — day 21, dose 2MedDRA: C-reactive protein, C-reactive protein increased — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Elevated CRPMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-10
-
2021-02-16
Survey response — day 35, dose 2MedDRA: Inflammatory marker increased, Lymphadenopathy, Mammogram abnormal, Medical counselling, Tumour marker increased — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Swollen lymph nodes right breast;,abnormal mammogram. Have elevated inflammation/cancer markers in lab results. Not sure of cause yet. To see hematologist · Healthcare visit (other): Hematologist referral; breast ultrasoundMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-25
Survey response — day 42, dose 2MedDRA: Fatigue, Malaise, Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Extrema fatigue, náusea, a sense of general malaiseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — 3 months, dose 2MedDRA: Arthralgia, Immunoglobulins increased, Office visit, Pelvic pain — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Severe joint and pelvis pain. Elevated immunoglobin protein. Now a patient at Texas Oncology seeing Hematologist.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-03
-
2022-01-12
Survey response — 12 months, dose 2MedDRA: Hypoglycaemia, Monoclonal immunoglobulin present — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Hypoglycemia, IgA Iambda monoclonal band present Fingerstick glucose and venous glucose do not match by more than 20-30MedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-01-13
- 2022-01-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Call center
5 call center cases
5 unsuccessful
Free text
Release 2 — day 14, dose 2
Symptoms: Generalized body aches
Release 3 — day 21, dose 2
Symptoms: Elevated CRP
Release 4 — day 35, dose 2
Symptoms: Swollen lymph nodes right breast;,abnormal mammogram. Have elevated inflammation/cancer markers in lab results. Not sure of cause yet. To see hematologist
Healthcare visit (other): Hematologist referral; breast ultrasound
Release 4 — day 42, dose 2
Symptoms: Extrema fatigue, náusea, a sense of general malaise
Release 7 — 3 months, dose 2
Symptoms: Severe joint and pelvis pain. Elevated immunoglobin protein. Now a patient at Texas Oncology seeing Hematologist.
Release 10 — 12 months, dose 2
Symptoms: Hypoglycemia, IgA Iambda monoclonal band present Fingerstick glucose and venous glucose do not match by more than 20-30
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| HCVO | Ultrasound breast | ○ | ○ | ○ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | C-reactive protein | ○ | ✓ | ○ |
| SD | C-reactive protein increased | ✓ | ○ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypoglycaemia | · | · | ✓ |
| SD | Immunoglobulins increased | · | · | ✓ |
| SD | Inflammatory marker increased | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Mammogram abnormal | ✓ | ✓ | ✓ |
| SD | Monoclonal immunoglobulin present | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pelvic pain | ✓ | ✓ | ✓ |
| SD | Tumour marker increased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release